Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 574
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT00006425 Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: … |
Breast Imaging Studies in Women a… | Cancer | À vérifier | COMPLETED | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2000-12-19 → 2008-10-03 | Ouvrir |
| NCT06835725 Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic … |
Stereotactic Body Radiation Thera… | Cancer | Phase 2 | RECRUITING | En attente / non publié | University of Wisconsin, Madison | Canada · BC Cancer Radiation Oncology, Surrey, Canada… | 2025-09-04 → 2033-04-30 | Ouvrir |
| NCT05041335 Wet Heparinized Suction for Abdominal Cancer |
Wet Heparinized Suction for Abdom… | Cancer | NA | NOT_YET_RECRUITING | En attente / non publié | H. Lee Moffitt Cancer Center and … | United States · Moffitt Cancer Center, Tampa, United … | 2026-03-15 → 2027-01-12 | Ouvrir |
| NCT02811354 Phase II Study of AZD9291 in Advanced Stage NSCLC With EGFR and T790M M… |
AZD9291 | Cancer | Phase 2 | UNKNOWN | En attente / non publié | National University Hospital, Sin… | Hong Kong, Singapore, South Korea, Taiwan, Thailand ·… | 2017-02-24 → 2020-02-24 | Ouvrir |
| NCT01078441 Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyc… |
liposomal doxorubicin | Cancer | Phase 2 | TERMINATED | En attente / non publié | Merck Sharp & Dohme LLC | United States · Abbott-Northwestern Hospital, Minneap… | 2010-09 → 2014-03 | Ouvrir |
| NCT06486441 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice i… |
Sacituzumab govitecan-hziy | Cancer | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Gilead Sciences | United States, Australia, Brazil, Canada, China, Czec… | 2024-08-28 → 2029-06 | Ouvrir |
| NCT02008383 Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorec… |
Panitumumab | Cancer | Phase 1 | COMPLETED | En attente / non publié | Verastem, Inc. | United States · Duke Cancer Center, Duke University M… | 2014-01 → 2018-08-29 | Ouvrir |
| NCT02403869 Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Li… |
Quality of Life in Metastatic Bre… | Cancer | À vérifier | COMPLETED | En attente / non publié | Celgene | Spain · Centro Médico Teknon, Barcelona, Spain | Comp… | 2014-03-12 → 2019-01-31 | Ouvrir |
| NCT03879694 Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neur… |
Incomplete Freund's Adjuvant | Cancer | Phase 1 | COMPLETED | En attente / non publié | Roswell Park Cancer Institute | United States · Roswell Park Cancer Institute, Buffal… | 2019-06-17 → 2025-03-14 | Ouvrir |
| NCT04233294 Addition of Chidamide to the Combination Treatment of Decitabine Plus C… |
Chidamide | Cancer | Phase 2 | UNKNOWN | En attente / non publié | Chinese PLA General Hospital | China · Biotherapeutic Department of Chinese PLA Gene… | 2020-02-02 → 2026-02 | Ouvrir |
| NCT03882866 Iodine-125 Seed Implantation Therapy for Locally Advanced Pancreatic Ca… |
3D-printed non-coplanar template | Cancer | NA | UNKNOWN | En attente / non publié | Ruijin Hospital | China · Anhui Provincial Hospital, Hefei, China | Chi… | 2019-03-28 → 2021-09-30 | Ouvrir |
| NCT05817994 Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry |
Endoscopic Ultrasound Guided Live… | Cancer | À vérifier | WITHDRAWN | En attente / non publié | Sheikh Shakhbout Medical City | Non communiqué | 2023-04-01 → 2023-04-01 | Ouvrir |
| NCT00861705 Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by D… |
Bevacizumab | Cancer | Phase 2 | COMPLETED | En attente / non publié | AbbVie | United States · Abbott-Northwestern Hospital, Minneap… | 2009-07-21 → 2025-09-02 | Ouvrir |
| NCT06746623 Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chr… |
Nonendoscopic Screening for Barre… | SEP | NA | RECRUITING | En attente / non publié | Louis Stokes VA Medical Center | United States · VA Northeast Ohio Healthcare System, … | 2025-04-11 → 2028-12-31 | Ouvrir |
| NCT02867397 Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Pati… |
Teysuno (S1) in combination with … | Cancer | Phase 1 | COMPLETED | En attente / non publié | Disphar International B.V. | Non communiqué | 2012-01 → 2015-08 | Ouvrir |
| NCT05982574 Tumor Microenvironment |
Tumor Microenvironment | Cancer | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | University Hospital Heidelberg | Non communiqué | 2016-02 → 2026-12 | Ouvrir |
| NCT00776074 A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Fema… |
Leuprorelin (GF) | Cancer | Phase 2 | COMPLETED | En attente / non publié | Takeda | Non communiqué | 2006-06 → 2007-07 | Ouvrir |
| NCT05392374 Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Ponti… |
ONC201 | Cancer | À vérifier | NO_LONGER_AVAILABLE | En attente / non publié | Jazz Pharmaceuticals | United States · Albany Medical Center, Albany, United… | Non communiqué | Ouvrir |
| NCT03543397 MRI in Ductal Carcinoma in Situ (DCIS) |
MRI in Ductal Carcinoma in Situ (… | Cancer | À vérifier | UNKNOWN | En attente / non publié | University Hospital, Strasbourg, … | France · Service de Radiologie 1, Strasbourg, France | 2018-02-26 → 2019-02 | Ouvrir |
| NCT00652080 An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ … |
API 31510 | Cancer | Phase 1 | COMPLETED | En attente / non publié | BPGbio | United States · Burke Pharmaceuticals, Hot Springs, U… | 2008-06 → 2010-01 | Ouvrir |
| NCT00003980 BIBX 1382 in Treating Patients With Solid Tumors |
BIBX 1382 | Cancer | Phase 1 | SUSPENDED | En attente / non publié | European Organisation for Researc… | Austria, Belgium, Denmark, France, Germany, Netherlan… | 1999-02 | Ouvrir |
| NCT03613259 Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or Hi… |
Fluorothymidine F-18 | Cancer | Phase 1 | WITHDRAWN | En attente / non publié | OHSU Knight Cancer Institute | Non communiqué | 2020-06-01 → 2022-06-01 | Ouvrir |
| NCT06979180 A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on… |
A Clinical Trial to Investigate t… | Cancer | NA | RECRUITING | En attente / non publié | Papillex Inc. | Canada · KGK Science Inc., London, Canada | 2026-03 → 2026-12 | Ouvrir |
| NCT02258659 Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy… |
paclitaxel albumin-stabilized nan… | Cancer | Phase 2 | COMPLETED | En attente / non publié | University of Chicago | United States · University of Chicago, Chicago, Unite… | 2014-09-22 → 2024-09-06 | Ouvrir |